D-0219-2018 Class III Terminated

Recalled by Shionogi Inc. — Alpharetta, GA

FDA drug recall D-0219-2018 was initiated by Shionogi Inc. on May 24, 2017 and is designated Class III. Reason for recall: Presence of foreign substance: The recall was initiated due to black particles being observed while performing routine post-release stability testing on Mefenamic acid capsules The recall status is terminated (terminated Feb 28, 2018). Affected quantity: 968 bottles.

Recall details

Product Type
Drugs
Report Date
Jan 24, 2018
Initiation Date
May 24, 2017
Termination Date
Feb 28, 2018
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
968 bottles

Product description

Mefenamic Acid Capsules, USP, 250 mg, 30-count bottle, Rx only, Distributed by Prasco Laboratories, Mason, OH 45040, Manufactured by Halo Pharmaceutical Inc., Whippany, NJ 07981, NDC 66993-070-30

Reason for recall

Presence of foreign substance: The recall was initiated due to black particles being observed while performing routine post-release stability testing on Mefenamic acid capsules

Distribution pattern

U.S.A. Nationwide

Code information

Lot#: 7H66200103G, Exp 12/19

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0219-2018
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0219-2018. Report a data issue: hello@regdatalab.com.